comparemela.com

Latest Breaking News On - Madrigal pharmaceuticals company profile - Page 1 : comparemela.com

Paulson & CO. Inc. Grows Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Paulson & CO. Inc. increased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 121.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,105,741 shares of the biopharmaceutical company’s stock after purchasing an additional 605,741 shares during the quarter. Madrigal […]

United-states
America
Jamesm-daly
Wolfe-research
Quarter-for-madrigal-pharmaceuticals
Madrigal-pharmaceuticals-company-profile
Exchange-commission
News-ratings-for-madrigal-pharmaceuticals-daily
Madrigal-pharmaceuticals-stock
Global-retirement-partners
Harbor-financial-group

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded by StockNews.com to "Sell"

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Wednesday. Other equities research analysts also recently issued research reports about the company. Piper Sandler restated an “overweight” rating and set a $336.00 price target on shares […]

New-york
United-states
Piper-sandler
Roberte-waltermire
Madrigal-pharmaceuticals-inc
York-state-common-retirement-fund
Madrigal-pharmaceuticals
Analyst-recommendations-for-madrigal-pharmaceuticals
Citigroup
Charles-schwab-investment-management-inc
Canaccord-genuity-group
News-ratings-for-madrigal-pharmaceuticals-daily

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded by StockNews.com to "Sell"

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Wednesday. Other equities research analysts also recently issued research reports about the company. Piper Sandler restated an “overweight” rating and set a $336.00 price target on shares […]

New-york
United-states
Roberte-waltermire
Piper-sandler
Canaccord-genuity-group
Citigroup
Charles-schwab-investment-management-inc
Madrigal-pharmaceuticals-company-profile
Hedge-funds-weigh-in-on-madrigal-pharmaceuticals
Jump-financial
Jp-morgan-private-wealth-advisors
Securities-exchange-commission

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have received an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating on the […]

United-states
America
Piper-sandler
Rebecca-taub
Canaccord-genuity-group
Analyst-recommendations-for-madrigal-pharmaceuticals
Global-retirement-partners
Madrigal-pharmaceuticals-inc
Madrigal-pharmaceuticals-stock-performance
Citigroup
Entrypoint-capital
Nasdaq

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United-states
Richards-levy
Piper-sandler
Paula-friedman
Madrigal-pharmaceuticals-stock-down
Canaccord-genuity-group
Citigroup
Madrigal-pharmaceuticals
Madrigal-pharmaceuticals-company-profile
News-ratings-for-madrigal-pharmaceuticals-daily
Nasdaq
Madrigal-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.